[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-LIMN":3,"homepage-market-summary":30,"stock-stats-LIMN":171},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"LIMN","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Liminatus Pharma, Inc. Class A Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.","1","Cerritos, CA",false,{"close":16,"open":17,"high":18,"low":17,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},3.99,3.8,4.08,3.9,0.09,2.31,17784.20051,523,3.9819,5.8756,0.094999999,13099693.164053777,67.4,359,{"status":31,"indices":32,"watchlist":75,"sectors":97,"benchmarks":151},"success",[33,41,48,55,62,68],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":38,"is_up":39,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":39,"sparkline":74,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[76,83,90],{"symbol":77,"name":78,"price":79,"change":80,"pct_change":81,"is_up":39,"sparkline":82,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":84,"name":85,"price":86,"change":87,"pct_change":88,"is_up":14,"sparkline":89,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":39,"sparkline":96,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[98,103,108,113,118,123,128,132,137,142,146],{"name":99,"etf":100,"change":101,"price":102,"is_up":39},"Technology","XLK",0.56,200.93,{"name":104,"etf":105,"change":106,"price":107,"is_up":39},"Financials","XLF",0.73,53.88,{"name":109,"etf":110,"change":111,"price":112,"is_up":39},"Healthcare","XLV",0.72,167.37,{"name":114,"etf":115,"change":116,"price":117,"is_up":39},"Consumer Cycl","XLY",0.35,110.42,{"name":119,"etf":120,"change":121,"price":122,"is_up":39},"Consumer Staples","XLP",0.63,81.04,{"name":124,"etf":125,"change":126,"price":127,"is_up":39},"Energy","XLE",0.99,63.44,{"name":129,"etf":130,"change":20,"price":131,"is_up":39},"Industrials","XLI",170.1,{"name":133,"etf":134,"change":135,"price":136,"is_up":39},"Materials","XLB",1.31,49.5,{"name":138,"etf":139,"change":140,"price":141,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":143,"etf":144,"change":116,"price":145,"is_up":39},"Utilities","XLU",39.97,{"name":147,"etf":148,"change":149,"price":150,"is_up":39},"Comm Services","XLC",1.17,111.61,[152,157,162,167],{"ticker":153,"name":154,"price":155,"change":156,"is_up":39},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":158,"name":159,"price":160,"change":161,"is_up":39},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":163,"name":164,"price":165,"change":166,"is_up":39},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":168,"name":169,"price":170,"change":38,"is_up":39},"IWM","iShares Russell 2000",283.39,{"ticker":4,"company_name":7,"current_price":16,"data_notice":172,"valuation":173,"dates":176,"share_statistics":178,"valuation_ratios":181,"enterprise_valuation":182,"financial_position":183,"financial_efficiency":185,"taxes":187,"price_statistics":188,"income_statement":194,"balance_sheet":196,"cash_flow":197,"margins":199,"dividends":200,"analyst_forecast":202,"fair_value":204,"splits":206,"fundamentals_available":14},"Dividend history, analyst price targets, ownership breakdown, short interest, stock splits, beta, WACC and Altman\u002FPiotroski scores are not available from any data source Bullzeno currently integrates, so those fields are omitted (null) rather than estimated.",{"market_cap":174,"enterprise_value":9,"summary":175},5238507.3,"LIMN has a market cap of $5,238,507.30.",{"latest_fiscal_period_end":9,"earnings_date":9,"ex_dividend_date":9,"summary":177},"No fundamental filing dates are available for this symbol.",{"shares_outstanding":179,"owned_by_insiders":9,"owned_by_institutions":9,"summary":180},1343207,"LIMN has 1,343,207 shares outstanding.",{"pe_ratio":9,"ps_ratio":9,"pb_ratio":9,"pfcf_ratio":9,"pocf_ratio":9},{"ev_earnings":9,"ev_sales":9,"ev_ebitda":9,"ev_ebit":9,"ev_fcf":9},{"current_ratio":9,"debt_equity":9,"debt_ebitda":9,"debt_fcf":9,"summary":184},"Balance sheet data is not available for this symbol.",{"roe":9,"roa":9,"revenue_per_employee":9,"profit_per_employee":9,"employee_count":186,"asset_turnover":9},1,{"income_tax":9},{"beta_5y":9,"price_change_52w":189,"ma_50":190,"ma_200":161,"rsi_14":191,"avg_volume_20d":192,"summary":193},130.64,2.47,62,24467,"The stock price has changed by +130.64% in the last 52 weeks.",{"revenue":9,"gross_profit":9,"operating_income":9,"pretax_income":9,"net_income":9,"ebitda":9,"ebit":9,"eps":9,"summary":195},"Income statement data is not available for this symbol.",{"cash_and_equiv":9,"total_debt":9,"net_cash":9,"net_cash_per_share":9,"equity_book_value":9,"book_value_per_share":9,"working_capital":9,"summary":184},{"operating_cash_flow":9,"capital_expenditures":9,"depreciation_amortization":9,"net_borrowing":9,"free_cash_flow":9,"fcf_per_share":9,"summary":198},"Cash flow data is not available for this symbol.",{"gross_margin":9,"operating_margin":9,"pretax_margin":9,"profit_margin":9,"ebitda_margin":9,"fcf_margin":9},{"dividend_per_share":9,"dividend_yield":9,"earnings_yield":9,"fcf_yield":9,"summary":201},"LIMN has no recorded dividend payments.",{"price_target":9,"price_target_diff":9,"consensus":9,"analyst_count":9,"summary":203},"Analyst price targets and consensus ratings are not available.",{"lynch_fair_value":9,"lynch_upside":9,"graham_number":9,"graham_upside":9,"summary":205},"Graham Number and Peter Lynch Fair Value are textbook valuation formulas applied to this company's real reported EPS and book value; they are estimates, not price targets or guarantees.",{"last_split_date":9,"split_type":9,"split_ratio":9,"summary":207},"Stock split history is not available for this symbol."]